Precision fermentation scale-up: pilot facilities and production costs

Precision fermentation uses microorganisms as production systems for a specified molecule or ingredient. Scaling it requires evidence that the organism, process and downstream recovery remain effective beyond the laboratory. Production cost depends on feedstock conversion, concentration, batch time, recovery yield, quality requirements and facility utilisation. A larger fermenter alone does not establish commercial readiness. The six research and pilot organisations below offer a non-exhaustive starting point for development work, with scope and availability to be confirmed for the actual organism and product.

What changes when fermentation moves beyond the laboratory?

Larger vessels create different mixing, oxygen-transfer, heat-removal and feeding conditions. A microorganism may encounter changing local conditions even when the average sensor reading appears acceptable. CPI's April 2026 account of its expanded food-pilot capability identifies mixing, oxygen transfer, feeding and downstream recovery as factors that can change yield, quality and economics during scale-up. A successful small culture therefore defines a starting point for engineering, not an assured factory recipe.

Agree which parameters are biologically important and which can be reproduced in a larger vessel. The scale-up plan should explain how strain performance will be evaluated under anticipated gradients and how contamination or an unsuccessful batch will be detected. Define the product's critical quality attributes before designing the trial. Producing more biomass is not necessarily the objective when value resides in a particular secreted or intracellular molecule.

Which pilot organisations provide relevant development capabilities?

CPI, United Kingdom, reports a food-bioprocessing route at its Novel Food Innovation Centre extending to two 750-litre pilot units, integrated with downstream processing and formulation. This is useful for teams needing representative ingredient material and scale-up data together. Confirm working volume, organism acceptance, containment and the intended use of material from the proposed campaign; a published vessel capacity does not guarantee a booking or product authorisation.

Bio Base Europe Pilot Plant, Belgium, offers process development, scale-up and custom manufacturing across biobased processes, including precision fermentation and downstream recovery. Its website describes fermentation capability up to 75,000 litres. That breadth can help connect fermentation with subsequent separation steps, but teams should verify which equipment train and quality framework are available for their molecule. Maximum vessel size alone says little about compatibility with a demanding process.

VTT, Finland, describes bench-to-pilot bioprocess development for multiple organism types, with monitored fermenters and separation and purification equipment. Its role is relevant where physiological characterisation and process engineering need to be developed together. Ask how the proposed experiments will reproduce the intended commercial environment, and which analyses and engineering data are included in the deliverables.

Danish Technological Institute, Denmark, offers laboratory and pilot work for development, testing and demonstration of fermentation processes, describing its facility as food-grade. This supports an enquiry about process development and sample production. Establish the specific production scope, cleaning regime, analytical support and permitted organisms rather than assuming that a general food-grade description covers every product and downstream operation.

CSIRO, Australia, describes precision-fermentation expertise including pilot-scale fermentation and ingredient development. Its research role can be relevant when strain, processing and food-function questions remain connected. The organisation also stresses the need for scientific evidence behind sustainability claims. A development programme should therefore identify whether it is generating process data, product samples, environmental evidence or several of these together.

QUT Pioneer BioPilot, Australia, describes an expanded capability that includes pilot-scale precision fermentation alongside broader bioprocessing. It provides another route for examining scale-up in a relevant infrastructure setting. Confirm the feedstock, fermenter and recovery configuration needed for the project, the facility's current operating scope and the quality status of material produced. The directory is a starting set of enquiries, not a claim that each site is interchangeable or globally available on demand.

Which metrics connect process performance to production cost?

Titre describes product concentration, yield relates product to consumed substrate, and productivity relates output to time and reactor volume. All three can matter, but optimising one can worsen another. A concentrated broth may reduce liquid handling while increasing viscosity or slowing production. Require definitions that specify whether the measured product is active, recoverable and within specification, rather than relying on a headline concentration that cannot be converted into saleable output.

Build the cost model around an accepted kilogram of ingredient at the required purity and form. Include feedstock and nutrients, utilities, labour, cleaning, analytical release, waste treatment, downstream processing, packaging and facility costs. Account for failed batches and time spent preparing and cleaning equipment. A plant with impressive fermentation performance can still have poor economics if recovery is inefficient or utilisation is too low.

For a hypothetical arithmetic example, a 10,000-litre batch at 50 grams per litre contains 500 kilograms of target product before recovery. At 80% recovery, 400 kilograms remain, before any further quality rejection. This does not describe a typical industrial process. It shows why a cost model based on the 500 kilograms in the fermenter can overstate the output available to pay for the batch.

Why must downstream recovery be part of the pilot?

The intended product may need separation from cells, concentration, purification and conversion into a stable commercial form. The appropriate sequence depends on where the product is located and its sensitivity to processing. A purified sample from a small laboratory method may not establish a workable larger-scale route. Measure recovery losses and product functionality after the complete sequence rather than assuming that fermentation output remains unchanged through processing.

Choose pilot equipment to resolve that question. A facility with the right fermenter but unsuitable recovery equipment may produce data that cannot support the next investment. Agree whether material transfers between facilities introduce holding times or stability questions. Retain a mass balance and records of quality at each significant boundary so that the source of losses can be identified.

What should a pilot contract and commercial decision include?

Define the organism, process scope, quality objectives, sampling plan, data access and ownership of improvements. Agree how unsuccessful runs are reported and paid for, and whether the project includes engineering documentation that a later manufacturer can use. Facility standards and regulatory approval of a particular ingredient are separate questions; confirm requirements for the intended market and use with appropriate specialists.

The investment decision should combine representative repeated runs, a reconciled cost model, a supply plan and an agreed route to product acceptance. A facility demonstration may justify another development campaign rather than immediate construction of a dedicated plant. The readiness guide provides a framework for stating that next milestone, while industrial water reuse addresses a relevant utility and residual-stream boundary as bioprocesses expand.